Here at DermaGlo we integrate Botulinum Toxin into our hair loss treatment protocols and it has revolutionized the way we address this common concern. Our combination treatment protocol has opened up exciting possibilities for individuals grappling with hair loss, offering a non-invasive and potentially transformative comprehensive approach to hair restoration.

A study done in 2020 has shed light on the promising use of Botox (BTA) for hair loss, opening new avenues for those seeking effective solutions. This study (https://pubmed.ncbi.nlm.nih.gov/32802833/, Zhou Y, Yu S, Zhao J, Feng X, Zhang M, Zhao Z. Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia. Biomed Res Int. 2020 Aug 4;2020:1501893. doi: 10.1155/2020/1501893. PMID: 32802833; PMCID: PMC7424364.), reveals compelling results that underscore the potential of BTA in enhancing hair growth and density.

The study followed 63 participants who underwent BTA treatment and after four sessions all the participants showed visible improvements in hair growth and density, coupled with a noticeable reduction in the area affected by hair loss, as evident in head photographs taken throughout the treatment process. The effectiveness rates were impressive, with the BTA group showing a 73.3% improvement and the BTA and oral Finasteride group boasting an even higher rate at 84.8% after four treatments over a year.

#HairLoss #BotulinumToxin #InnovationInTheBeautyIndustry #drvinitasharma #dermaglo #androgeneticalopecia #hair #AGA #hairgrowth